Rockefeller Capital Management’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
Rockefeller Capital Management's CVAC Position: Q1 2026 in Review
Rockefeller Capital Management sold out of CureVac (CVAC) in Q1 2026, closing a stake of 23 shares — an estimated $104 sold.
Rockefeller Capital Management first reported a position in CVAC in Q3 2025 and held it in 2 quarters. The position peaked at $868 in Q3 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Rockefeller Capital Management reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Rockefeller Capital Management sold 23 CureVac shares in Q1 2026, an estimated $104.
- Rockefeller Capital Management first reported a position in CureVac in Q3 2025 and held it in 2 quarters.
- Rockefeller Capital Management's CureVac position peaked at $868 in Q3 2025.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.